[
    [
        {
            "time": "",
            "original_text": "科創板半日成交150億！安集科技、南微醫學、樂鑫科技……誰會成為市場領頭羊？",
            "features": {
                "keywords": [
                    "科創板",
                    "成交額",
                    "安集科技",
                    "南微醫學",
                    "樂鑫科技"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技",
                    "醫療"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "科創板半日成交150億！安集科技、南微醫學、樂鑫科技……誰會成為市場領頭羊？",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "生物醫藥行業動態跟蹤報告:疫苗批簽發跟蹤,逐月小幅增加,上半年總量偏少",
            "features": {
                "keywords": [
                    "生物醫藥",
                    "疫苗",
                    "批簽發",
                    "增長"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "醫療",
                    "生物技術"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "生物醫藥行業動態跟蹤報告:疫苗批簽發跟蹤,逐月小幅增加,上半年總量偏少",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "醫藥生物行業跨市場周報:仿製藥價格體系加速重塑,藥企邁向體系競爭時代",
            "features": {
                "keywords": [
                    "醫藥生物",
                    "仿製藥",
                    "價格體系",
                    "體系競爭"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "醫療",
                    "生物技術"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "醫藥生物行業跨市場周報:仿製藥價格體系加速重塑,藥企邁向體系競爭時代",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]